tradingkey.logo
tradingkey.logo
Search

Immuneering Corp

IMRX
Add to Watchlist
4.130USD
-0.100-2.36%
Close 07-31 16:00ETQuotes delayed by 15 min
267.20MMarket Cap
LossP/E TTM

IMRX Financials

See Immuneering Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Immuneering Corp Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.21/-0.25
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.27
37.47%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
50.84%-0.21
69.26%-0.18
22.88%-0.38
15.53%-0.40
13.07%-0.42
-12.82%-0.58
-13.66%-0.49
-11.60%-0.47
5.31%-0.49
-2.71%-0.52
---0.43
---0.43
---0.51
---0.50
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-99.76%455.00
-92.04%38.38K
-85.69%94.42K
-75.45%183.70K
--189.59K
--482.13K
37.27%660.04K
Net Profit
10.54%-13.46M
35.85%-11.58M
-2.52%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-19.68%-18.05M
-15.90%-14.60M
-15.52%-14.08M
-5.17%-14.31M
-13.88%-15.08M
1.94%-12.60M
-5.74%-12.19M
-5.49%-13.60M
-22.82%-13.25M
-50.51%-12.84M
-44.31%-11.53M
-107.02%-12.90M
---10.78M
---8.53M
-121.62%-7.99M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
---2911112.31%
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
---1507.91%
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-99.76%455.00
-92.04%38.38K
-85.69%94.42K
-75.45%183.70K
--189.59K
--482.13K
37.27%660.04K
Operating profit
0.97%-15.34M
25.89%-13.75M
-0.70%-15.38M
1.05%-14.76M
-1.04%-15.48M
-13.84%-18.56M
-9.68%-15.27M
-10.43%-14.91M
-4.40%-15.33M
-16.57%-16.30M
-5.60%-13.93M
-15.96%-13.50M
-13.57%-14.68M
-25.81%-13.99M
-54.37%-13.19M
-45.74%-11.65M
-107.27%-12.93M
---11.12M
---8.54M
-121.56%-7.99M
Net Profit
10.54%-13.46M
35.85%-11.58M
-2.52%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-19.68%-18.05M
-15.90%-14.60M
-15.52%-14.08M
-5.17%-14.31M
-13.88%-15.08M
1.94%-12.60M
-5.74%-12.19M
-5.49%-13.60M
-22.82%-13.25M
-50.51%-12.84M
-44.31%-11.53M
-107.02%-12.90M
---10.78M
---8.53M
-121.62%-7.99M
Current assets
322.47%161.41M
345.21%176.25M
314.59%229.10M
-56.47%27.73M
-48.68%38.21M
-55.56%39.59M
-45.06%55.26M
-42.89%63.69M
-21.00%74.45M
-18.08%89.08M
-16.20%100.58M
-13.67%111.51M
-32.46%94.23M
-28.61%108.75M
-21.71%120.02M
151.12%129.17M
333.56%139.53M
--152.33M
--153.31M
--51.44M
Total current liabilities
-2.62%4.97M
34.25%10.07M
37.94%9.55M
10.41%7.49M
-1.34%5.11M
-4.36%7.50M
23.08%6.92M
23.77%6.78M
-6.30%5.18M
-2.59%7.85M
-22.51%5.62M
44.16%5.48M
50.41%5.53M
42.96%8.05M
37.76%7.26M
-21.35%3.80M
33.20%3.67M
--5.63M
--5.27M
--4.83M
Total assets
323.84%214.81M
340.08%231.99M
251.61%241.06M
-48.04%40.06M
-42.40%50.68M
-48.61%52.71M
-39.80%68.56M
-38.28%77.09M
-18.30%87.98M
-16.17%102.58M
-14.82%113.88M
-12.08%124.90M
-29.35%107.70M
-26.60%122.37M
-18.50%133.69M
167.81%142.05M
363.97%152.45M
--166.70M
--164.04M
--53.04M
Total liabilities
-6.19%8.29M
19.18%13.50M
20.70%13.08M
3.14%11.12M
-4.55%8.84M
-5.66%11.33M
9.86%10.84M
10.12%10.78M
-6.53%9.26M
-4.06%12.01M
-16.40%9.86M
15.80%9.79M
18.06%9.91M
16.71%12.52M
105.23%11.80M
58.48%8.46M
155.65%8.39M
--10.72M
--5.75M
--5.34M
Total equity
393.56%206.52M
427.91%218.48M
294.96%227.98M
-56.36%28.94M
-46.85%41.84M
-54.31%41.39M
-44.51%57.72M
-42.40%66.31M
-19.50%78.72M
-17.55%90.58M
-14.66%104.02M
-13.84%115.10M
-32.12%97.79M
-29.57%109.85M
-23.00%121.89M
180.03%133.59M
387.09%144.06M
--155.98M
--158.29M
--47.71M
Net operating income
-30.91%-18.43M
32.18%-9.84M
11.10%-11.98M
18.04%-9.45M
9.11%-14.08M
-23.23%-14.51M
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
-0.23%-11.78M
-13.22%-12.03M
-13.75%-10.75M
-17.40%-14.42M
-27.16%-11.75M
-17.57%-10.62M
-46.79%-9.45M
-100.02%-12.28M
---9.24M
---9.03M
-91.17%-6.44M
Net investment
-704995.30%-63.07M
-1715.84%-88.72M
99.87%-7.25K
-100.04%-2.12K
-100.04%-8.95K
75.26%5.49M
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
-61.57%3.13M
-2623.83%-23.97M
-58.64%9.16M
52.94%18.97M
135.74%8.15M
98.33%-880.08K
111852.97%22.15M
74990.38%12.40M
---22.81M
---52.77M
-266.84%-19.82K
Net financing
-98.69%180.76K
-772.26%-357.52K
4784.59%213.19M
---61.96K
1309.35%13.81M
-623.14%-40.99K
20249.61%4.36M
-100.00%0.00
309.31%979.92K
104.24%7.83K
224.60%21.45K
101297.86%28.17M
23.97%239.41K
-2556.14%-184.68K
-100.01%-17.21K
-99.89%27.78K
--193.11K
--7.52K
--118.49M
--25.77M

FAQs

What are the current assets of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its current assets were 176.25M, with a year-on-year change of 345.21.

What are the total assets of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its total assets of Immuneering Corp were 231.99M, with a year-on-year change of 340.08.

What are the total liabilities of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its total liabilities of Immuneering Corp were 13.50M, with a year-on-year change of 19.18.

What is the total equity of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its total equity of Immuneering Corp was 218.48M, with a year-on-year change of 427.91.

What is the net operating income of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its net operating income of Immuneering Corp was -59.38M, with a year-on-year change of 7.33.

What is the net investment of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its net investment of Immuneering Corp was -88.74M, with a year-on-year change of -435.69.

What is the net financing of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its net financing of Immuneering Corp was 226.58M, with a year-on-year change of 4172.32.

What is the Earnings Per Share (EPS) of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -1.27, with a year-on-year change of 37.47.

What is the net income of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its net income was -56.02M, with a year-on-year change of 8.21.

What is the Return on Equity (ROE) of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its Return on Equity (ROE) was -43.12, with a year-on-year change of 53.39.

What is the Return on Assets (ROA) of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its Return on Assets (ROA) was -39.36, with a year-on-year change of 49.93.

What is the operating profit of Immuneering Corp?

According to Immuneering Corp's FY2025 earnings report, its operating profit was -59.38M, with a year-on-year change of 7.33.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.